» Articles » PMID: 39628626

Extrachromosomal DNA: Molecular Perspectives in Aging and Neurodegenerative Diseases

Overview
Date 2024 Dec 4
PMID 39628626
Authors
Affiliations
Soon will be listed here.
Abstract

Extrachromosomal DNA (ecDNA) refers to a class of circular, non-chromosomal DNA that has recently gained widespread attention due to its potential role in aging and neurodegenerative diseases. The generation of ecDNA is closely associated with processes such as double-strand breaks, micronuclei formation, and the breakage-fusion-bridge (BFB) cycle, all of which are integral to regulation of gene expression, genetic stability, and clonal evolution. In neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, the aberrant formation of ecDNA is closely linked to defects in DNA repair, alterations in synaptic plasticity, and neuronal dysfunction. The distinct distribution and functional roles of ecDNA in these conditions make it a potential diagnostic biomarker and therapeutic target. This review provides an overview of the mechanisms underlying ecDNA formation and its functions in the nervous system. Additionally, it explores the clinical potential of ecDNA in disease diagnosis, targeted therapy, and personalized medicine, offering new insights for future research and treatment strategies.

References
1.
Goker E, Waltham M, Kheradpour A, Trippett T, Mazumdar M, Elisseyeff Y . Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutations. Blood. 1995; 86(2):677-84. View

2.
Schaser A, Osterberg V, Dent S, Stackhouse T, Wakeham C, Boutros S . Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders. Sci Rep. 2019; 9(1):10919. PMC: 6662836. DOI: 10.1038/s41598-019-47227-z. View

3.
Enokido Y, Tamura T, Ito H, Arumughan A, Komuro A, Shiwaku H . Mutant huntingtin impairs Ku70-mediated DNA repair. J Cell Biol. 2010; 189(3):425-43. PMC: 2867301. DOI: 10.1083/jcb.200905138. View

4.
Savelyeva L, Schwab M . Amplification of oncogenes revisited: from expression profiling to clinical application. Cancer Lett. 2001; 167(2):115-23. DOI: 10.1016/s0304-3835(01)00472-4. View

5.
Holland A, Cleveland D . Chromoanagenesis and cancer: mechanisms and consequences of localized, complex chromosomal rearrangements. Nat Med. 2012; 18(11):1630-8. PMC: 3616639. DOI: 10.1038/nm.2988. View